These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35291607)

  • 41. Anti-Carbamylated Protein Antibodies, Tumour Necrosis Factor Alpha and Insulin Resistance in Egyptian Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus.
    El Hawary MS; Hassan SA; ELatty SA; Khalil NM
    Reumatol Clin (Engl Ed); 2021 Jul; ():. PubMed ID: 34266801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-α inhibitors correlates with increased soluble Fas levels.
    Romano E; Terenzi R; Manetti M; Peruzzi F; Fiori G; Nacci F; Bellando-Randone S; Matucci-Cerinic M; Guiducci S
    J Rheumatol; 2014 Oct; 41(10):1961-5. PubMed ID: 25179850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long non-coding RNA THRIL predicts increased acute respiratory distress syndrome risk and positively correlates with disease severity, inflammation, and mortality in sepsis patients.
    Wang Y; Fu X; Yu B; Ai F
    J Clin Lab Anal; 2019 Jul; 33(6):e22882. PubMed ID: 31257645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.
    Niki Y; Takeuchi T; Nakayama M; Nagasawa H; Kurasawa T; Yamada H; Toyama Y; Miyamoto T
    PLoS One; 2012; 7(5):e37447. PubMed ID: 22629396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA THRIL inhibits miRNA-24-3p to upregulate neuropilin-1 to aggravate cerebral ischemia-reperfusion injury through regulating the nuclear factor κB p65 signaling.
    Kuai F; Zhou L; Zhou J; Sun X; Dong W
    Aging (Albany NY); 2021 Mar; 13(6):9071-9084. PubMed ID: 33675584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
    Ramírez J; Inciarte-Mundo J; Cuervo A; Ruiz-Esquide V; Hernández MV; Sanmartí R; Cañete JD
    Clin Exp Rheumatol; 2017; 35(1):74-79. PubMed ID: 27749227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor necrosis factor receptor-associated factor (TRAF) 6 inhibition mitigates the pro-inflammatory roles and proliferation of rheumatoid arthritis fibroblast-like synoviocytes.
    Zhu LJ; Yang TC; Wu Q; Yuan LP; Chen ZW; Luo MH; Zeng HO; He DL; Mo CJ
    Cytokine; 2017 May; 93():26-33. PubMed ID: 28506571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA NEAT1 regulates the proliferation and production of the inflammatory cytokines in rheumatoid arthritis fibroblast-like synoviocytes by targeting miR-204-5p.
    Xiao J; Wang R; Zhou W; Cai X; Ye Z
    Hum Cell; 2021 Mar; 34(2):372-382. PubMed ID: 33394349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of circulating and crevicular matrix metalloproteinase-9 in rheumatoid arthritis-chronic periodontitis association.
    Silosi I; Cojocaru M; Foia L; Boldeanu MV; Petrescu F; Surlin P; Biciusca V
    J Immunol Res; 2015; 2015():218060. PubMed ID: 25821836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.
    Catrina AI; Lampa J; Ernestam S; af Klint E; Bratt J; Klareskog L; Ulfgren AK
    Rheumatology (Oxford); 2002 May; 41(5):484-9. PubMed ID: 12011369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of tumor necrosis factor α in rheumatoid arthritis.
    Kulp W; Corzillus M; Greiner W; Pientka L; Siebert U; von der Schulenburg JM; Wasem J
    GMS Health Technol Assess; 2005 Dec; 1():Doc12. PubMed ID: 21289933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients.
    Fujita Y; Asano T; Matsuoka N; Temmoku J; Sato S; Matsumoto H; Furuya MY; Suzuki E; Watanabe H; Kawakami A; Migita K
    Arthritis Res Ther; 2020 Apr; 22(1):80. PubMed ID: 32293530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
    Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B
    Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The application of matrix metalloproteinase-3 and 7 joints ultrasonic score in assessment of disease activity in patients with rheumatoid arthritis].
    Zhou L; Song J; Chen L; Xu HJ
    Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):531-4. PubMed ID: 27373288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3.
    Kanai T; Kondo N; Okada M; Sano H; Okumura G; Kijima Y; Ogose A; Kawashima H; Endo N
    J Orthop Surg Res; 2020 Mar; 15(1):87. PubMed ID: 32131874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Correlation analysis of Sema4D with rheumatoid arthritis disease activity, bone destruction and rheumatoid arthritis-related interstitial lung disease].
    Yang QZ; Ma XB; Li YH; Li YN; Zhong YC; Zhang XW
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(20):1567-1572. PubMed ID: 32450646
    [No Abstract]   [Full Text] [Related]  

  • 57. High IL-23 level is a marker of disease activity in rheumatoid arthritis.
    Abu Al Fadl EM; Fattouh M; Allam AA
    Egypt J Immunol; 2013; 20(2):85-92. PubMed ID: 24617049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stachys schtschegleevii tea, matrix metalloproteinase, and disease severity in female rheumatoid arthritis patients: a randomized controlled clinical trial.
    Mirtaheri E; Khabbazi A; Nazemiyeh H; Ebrahimi AA; Hajalilou M; Shakibay Novin Z; Pirouzpanah S
    Clin Rheumatol; 2022 Apr; 41(4):1033-1044. PubMed ID: 34766228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyr61 participates in the pathogenesis of rheumatoid arthritis via promoting MMP-3 expression by fibroblast-like synoviocytes.
    Zhai T; Gao C; Huo R; Sheng H; Sun S; Xie J; He Y; Gao H; Li H; Zhang J; Li H; Sun Y; Lin J; Shen B; Xiao L; Li N
    Mod Rheumatol; 2017 May; 27(3):466-475. PubMed ID: 27585710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.